Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 465
Immune Disorders Drugs 194
Cardiovascular Drugs 153
Biopharmaceuticals 131
Infectious Diseases Drugs 121
Central Nervous System Drugs 104
Drug Discovery 102
Endocrine and Metabolic Disorders Drugs 102
Musculoskeletal Disorders Drugs 93
Clinical Trials 90
Pharmaceuticals 89
Leukemia Drugs 82
Hematological Drugs 81
Liver and Kidney Disorders Drugs 74
Lymphoma Drugs 64
Dermatological Drugs 58
Diabetes Drugs 54
Skin Cancer Drugs 50
Brain Cancer Drugs 47
Mental Disorders Drugs 41
Lung Cancer Drugs 40
Respiratory Drugs 38
Immunosuppressive Drugs 36
Gastrointestinal Drugs 34
Drug Delivery 32
Infusions and Injectables 31
Pharmaceutical Intermediates 30
Liver Cancer Drugs 30
Pharmaceutical Manufacturing 27
Analgesics 26
Bladder Cancer Drugs 25
Drugs by Therapeutic Area 23
Kidney Cancer Drugs 22
Antibiotics 22
HIV/AIDS Drugs 22
Breast Cancer Drugs 18
Ovarian Cancer Drugs 17
Colon Cancer Drugs 17
Cervical Cancer Drugs 17
Pancreatic Cancer Drugs 17
Psoriasis Drugs 17
Prostate Cancer Drugs 16
Urological Disorders Drugs 16
Schizophrenia Drugs 15
Thyroid Cancer Drugs 14
Sexual and Reproductive Health Drugs 14
Cancer Vaccines 13
Over the Counter (OTC) Drugs 12
Biosimilars and Biosuperiors 10
Optical Disorders Drugs 8
Generic Drugs 8
Alzheimer's Disease Drugs 8
Transdermal and Transmucosal Drug Delivery 7
Vaccines 7
Uterine Cancer Drugs 7
Cough and Cold Drugs 6
Anti-Obesity Drugs 6
Anxiety Drugs 6
Company Reports 5
Pharmacoeconomics 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

2,377 Results (Page 62 of 119)
- Relevance
  Sort by

Autoinjectors Market by Usage (Disposable, Reusable), Technology (Manual, Automatic), Therapy (Rheumatoid Arthritis, Diabetes, Obesity, Anaphypaxis, Multiple Sclerosis), Route of Administration (SC, IM), Volume (<3ml, >3ml) - Global Forecast to 2030

 Report
March 2025
384 Pages
Global

From

€4379EUR$4,950USD£3,799GBP

Active Pharmaceutical Ingredient (API) Market in the US 2025-2029

 Report
May 2025
177 Pages
United States

From

€2212EUR$2,500USD£1,919GBP

Antibody Drug Conjugates Market Report 2025-2035

 Report
December 2024
342 Pages
Global

From

€5190EUR$6,071USD£4,350GBP

Autism - Global Clinical Trials Review, 2022

 Clinical Trials
January 2022
419 Pages
Global

From

€2212EUR$2,500USD£1,919GBP

Oncology Precision Medicine Market: Industry Trends and Global Forecasts to 2035: Distribution by Type of Cancer Targeted, Route of Administration, Type of Molecule, Drug Class, Key Geographical Regions, Leading Drug Developers and Sales Forecasts

 Report
March 2025
468 Pages
Global

From

€4246EUR$4,799USD£3,683GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Market Forecasts for Immuno-Oncology Diagnostics Including Executive/Consultant Guides and Customized Forecasting/Analysis

 Report
May 2025
472 Pages
Global

From

€6189EUR$6,995USD£5,369GBP

T-Cell Therapy Market by Type of Therapy, Target Indication, Target Antigen, Company Size, Geographical Regions, Leading Players and Sales Forecast of Therapies, Industry Trends and Global Forecasts to 2035

 Report
March 2025
1048 Pages
Global

From

€4246EUR$4,799USD£3,683GBP

Anti-obesity Drug Market Forecasts from 2023 to 2028

 Report
October 2023
140 Pages
Global

From

€3937EUR$4,450USD£3,415GBP

TCR Therapy Market Industry Trends and Global Forecasts to 2035, by Target Indication, Target Antigen, Key Players and Key Geographies

 Report
January 2025
363 Pages
Global

From

€4246EUR$4,799USD£3,683GBP

Rheumatoid Arthritis - Pipeline Review, H2 2020

 Drug Pipelines
July 2020
1191 Pages
Global

From

€2212EUR$2,500USD£1,919GBP

Anti-Obesity Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

 Report
April 2023
137 Pages
Global

From

€4202EUR$4,750USD£3,646GBP

Androgen Deprivation Therapy - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
110 Pages
Global

From

€4202EUR$4,750USD£3,646GBP

Vaginitis Therapeutics Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3972EUR$4,490USD£3,446GBP

Non-cancerous Skin Diseases Therapeutics Market 2025-2029

 Report
February 2025
222 Pages
Global

From

€2212EUR$2,500USD£1,919GBP

Artificial Intelligence (AI) in Biopharmaceuticals Market Report 2023-2033

 Report
June 2023
218 Pages
Global

From

€4713EUR$5,513USD£3,950GBP

Cancer Biologics Market Report 2023-2033

 Report
June 2023
308 Pages
Global

From

€4713EUR$5,513USD£3,950GBP

Transdermal Drug Delivery System Market Outlook 2026-2034: Market Share, and Growth Analysis by Type, Application, End User, Technology

 Report
January 2026
160 Pages
Global

From

€2971EUR$3,358USD£2,577GBP

€3495EUR$3,950USD£3,032GBP

Idiopathic Pulmonary Fibrosis (IPF) Market 2025-2029

 Report
February 2025
218 Pages
Global

From

€2212EUR$2,500USD£1,919GBP

Idiopathic Pulmonary Fibrosis (IPF) Market (2023 Edition): Analysis By Drug Type (Pirfenidone, Nintedanib, Others), Route of Administration (Oral, Parenteral, Others), Distribution Channel, By Region, By Country: Market Insights and Forecast (2019-2029)

 Report
July 2023
260 Pages
Global

From

€2168EUR$2,450USD£1,880GBP

Chronic Venous Occlusions Treatment - Global Strategic Business Report

 Report
April 2026
282 Pages
Global

From

€5176EUR$5,850USD£4,490GBP

2,377 Results (Page 62 of 119)
- 1
- 60
- 61
- 62
- 63
- 64

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.